South West London Pathology Picks CliniSys for Next Generation LIMS

CliniSys One of the first pathology networks in the country, set up to serve more than two million people in south west London, has signed a contract with CliniSys for a new laboratory information management system (LIMS). South West London Pathology, which was established in 2014, is now working with the company to prepare to deploy WinPath Enterprise.

The award-winning NHS pathology networkwas set up by St George's University Hospitals NHS Foundation Trust, Croydon Health Services NHS Trust and Kingston Hospital NHS Foundation Trust to provide a single, integrated pathology service across south west London and beyond.

It operates on a ‘hub and spoke’ model, with a main hub laboratory at St George's Hospital and spoke sites at Croydon and Kingston to manage urgent local work.

The new LIMS will replace the mix of legacy systems used by the different services run out of these labs, including the iLab APEX LIMS at St George’s and older versions of WinPath used at Kingston and Croydon.

WinPath Enterprise is a next generation LIMS, designed to meet the requirements of the growing number of pathology networks that are being set up to improve the availability and efficiency of clinical tests for NHS providers.

Its deployment by South West London Pathology will enable all the network’s sites to use a single database, with better reporting and analytics tools. The roll-out of the new system will be phased andthe aim is to make the first service live by the end of 2019 and all sites and services live within 18 months.

Simon Brewer, managing director of South West London Pathology, said: “We have a 25-year old LIMS that was never designed to support a network, and we have created so many workarounds that it is no longer sustainable.

"We need a LIMS that can do a lot more; one that will enable us to further harmonise our workflow and enable us to grow. WinPath Enterprise has already been deployed into large, networked environments, so we are confident that CliniSys can help us to further modernise and streamline our service."

Donald Saum, business development director at CliniSys, said: "South West London Pathology has used an integration strategy to enable information to flow between systems, but there comes a point when you need to take a consolidation approach.

"That is what WinPath Enterprise will enable the network to do, while also laying the foundations for further consolidation and growth. We are delighted to be working with the network as it takes that next step."

South West London Pathology was set up in response to a national report on pathology services conducted by Lord Carter of Coles and the Modernising Pathology in London Programme. The Carter report argued there was a strong case for the consolidation of pathology services, so non-urgent and more specialist work could be carried in laboratories with the staff and resources to ensure high-quality results.

A number of pathology networks have now been set up or are being developed in response to a second report from Lord Carteron efficiencyand the recent NHS Long Term Plan. WinPath Enterprise responds to their need for a modern LIMS that can effectively manage tests conducted at multiple sites.

At South West London Pathology, the new LIMS will have to be integrated with the electronic patient record systems used by the different partner trusts; and the seven order communications systems used to order different tests from across the network.

To support the integration, the Rhapsody integration engine that was developed by Orion Health and recently sold to Hg Capitalis being layered into the CliniSys solution and will be delivered as part of the contract.

About South West London Pathology

South West London Pathology is an award winning pathology partnership set up by St George's University Hospitals NHS Foundation Trust, Kingston Hospital NHS Foundation Trust and Croydon Health Services NHS Trust to provide a single, integrated service across south west London and beyond.

About CliniSys

The CliniSys Group has been successfully developing and deploying laboratory IT systems for over 30 years. Its first go-live was in 1987, starting rapid growth in North East Europe. The group has expanded across the UK and Belgium, into Ireland, the Netherlands and Luxembourg. CliniSys is now the market leader in all of these territories.

Headquartered in Chertsey, Surrey, CliniSys currently provides systems to in excess of 2,000 laboratories across 30 countries and employs some 230 dedicated pathology IT professionals. Since joining forces with Sunquest ICE, its software is now running in over 75% of trusts across the NHS. Please visit www.clinisys.co.uk for more information.

About WinPath Enterprise

WinPath is the UK’s leading laboratory information system (LIMS). Combining proven performance with pioneering innovation, WinPath has been specifically developed to support the challenges and opportunities facing pathology as a key clinical service within the integrated healthcare community.

As a Windows based application, WinPath delivers a familiar look and feel, is easy to navigate and intuitive in use. WinPath is a functionally rich, financially aware system, with inbuilt business intelligence tools. It is a highly flexible system that enables users to adapt to change and secure the benefits afforded through the adoption of modern and Lean workflows, service optimisation and interoperability.

With more WinPath Enterprise multi-site operations than any other LIMS provider in the UK, CliniSys has extensive experience of working with trusts to develop and implement pathology networks to ensure that the investment in the network is realised in improved patient services and reduced costs. Some of these networks cover whole counties and are mission critical for maintaining a vital support service to ensure continuity of care for major hospitals.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...